# Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)

> **NCT00869856** · PHASE3 · WITHDRAWN · sponsor: **Sandoz**

## Conditions studied

- Anemia
- Chronic Renal Insufficiency

## Interventions

- **DRUG:** HX575 solution for s.c. administration

## Key facts

- **NCT ID:** NCT00869856
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-04
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** investigation of adverse events in a related clinical study
- **Last updated:** 2015-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00869856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00869856, "Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00869856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*